Synthetic RNA vaccine technology has the potential to substantially shorten the time frame between pathogen sequence acquisition in the field to vaccine manufacturing.
Synthetic RNA vaccine technology has the potential to substantially shorten the time frame between pathogen sequence acquisition in the field to vaccine manufacturing.